Compugen Ltd (CGEN) stock: insider buying, earnings and risk | BrightDollar

COMPUGEN LTD · Biotech

CGEN

Low riskNext report: Not enough history

The short version

A profitable company with growing sales.

Going well

Profitable, keeps 49% of sales as profit
Sales up 161% last year
Brings in more cash than it spends

Money moves

No insider buying or selling in the last 30 days
Institutions cut 0.4% from their holdings in the quarter ending June 2026 (30 bought, 31 sold)
Held by Cathie Wood (ARK Invest)

Facts from SEC filings, not a recommendation.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

4/6Mixed

PassReturn on equity 15%+Earns a lot on the money owners have in the business.44.8%
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.48.6%
MissProfitable every yearSteady profits, not one good year.1 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$31.3M
MissShare count not growingNot diluting owners. Falling means buybacks.+8.4% in 3 years
PassGross margin 40%+Pricing power: sells for well above what it costs to make.87.3%

Revenue: $72.8M; +161.1% vs prior year
5-year growth: +105.2%/yr; revenue, per year
Current ratio: 6.56x; short-term assets / bills due
Free cash flow: $31.3M; 43.1% of revenue

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: debt under half of equity. A checklist is a starting point for research, not a verdict.

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 1.3
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Steady-0.4%

Institutions cut 0.4% from their holdings. 30 bought, 31 sold.

Shares held by institutions14.1M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+3.0%

Cash runwayAt last year's cash burn

Cash flow positive

Shares outstandingLatest reported

95M

Earnings reports

Last 0

Next reportNot enough history

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

F-3May 18 · View filing ↗Offering

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

6-KSep 10 · Form 6-K ↗UPLOADAug 4 · Form UPLOAD ↗6-KAug 3 · Form 6-K ↗6-KAug 3 · Form 6-K ↗

Stock awardMichelle MahlerChief Medical Officer

13,500 shares

+58% of holdings
Now owns 36,625 shares
Exercise price $2.26
Filed 1 day after trade

Jul 29Form 4 ↗

Stock awardSanford S ZweifachDirector

7,500 shares

+59% of holdings
Now owns 20,180 shares
Exercise price $2.26
Filed 1 day after trade

Jul 29Form 4 ↗

Stock awardGilead HalevyDirector

7,500 shares

+66% of holdings
Now owns 18,907 shares
Exercise price $2.26
Filed 1 day after trade

Jul 29Form 4 ↗

Stock awardMathias HukkelhovenDirector

7,500 shares

+75% of holdings
Now owns 17,500 shares
Exercise price $2.26
Filed 1 day after trade

Jul 29Form 4 ↗

Stock awardSavitzky Kinneret LivnatDirector

7,500 shares

+56% of holdings
Now owns 20,850 shares
Exercise price $2.26
Filed 1 day after trade

Jul 29Form 4 ↗

Stock awardRusso Sharon KredoSVP, Research & Discovery

18,000 shares

+92% of holdings
Now owns 37,500 shares
Exercise price $2.26
Filed 1 day after trade

Jul 29Form 4 ↗

Insider tradeJul 30 · Form 4 ↗Insider tradeJul 30 · Form 4 ↗Insider tradeJul 30 · Form 4 ↗Insider tradeJul 30 · Form 4 ↗Insider tradeJul 30 · Form 4 ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page